In Systemic Lupus Erythematosus

Total Page:16

File Type:pdf, Size:1020Kb

In Systemic Lupus Erythematosus Ann Rheum Dis: first published as 10.1136/ard.39.4.312 on 1 August 1980. Downloaded from Annals of the Rheumatic Diseases, 1980, 39, 312-317 Evidence of an immediate hypersensitivity mechanism in systemic lupus erythematosus J. EGIDO, M. SANCHEZ CRESPO, C. LAHOZ, R. GARCIA, M. LOPEZ-TRASCASA, AND L. HERNANDO From the Renal and Immunology Laboratories, Fundacio'n Jimnunez Diaz, Madrid SummARY In 30 patients with systemic lupus erythematosus the number of circulating basophils was counted in different stages of activity. An inverse correlation was found between the absolute basophil count and anti-DNA antibodies and presumptive circulating immune complexes (as judged by polyethylene glycol precipitation of serum). A positive correlation was found between the absolute basophil count and C3 or C4 levels. IgE on the basophil surface was determined by radioimmunoassay in 7 patients. All of them showed a significantly high surface IgE number. When the count of circulating basophils was roughly normal, 5 out of the 6 patients showed a positive basophil degranulation test with native DNA. These results suggest the existence of an anti-DNA specific IgE in lupus patients. Depression of the circulating basophil count may be a useful index of lupus activity. copyright. In the acute serum sickness of rabbits the deposition Materials and methods of immune complexes in the blood-vessel walls involves an increase in vascular permeability induced We studied 30 patients with systemic lupus ery- by the release ofvasoactive amines from the platelets.' thematosus, who fulfilled diagnostic clinical criteria http://ard.bmj.com/ In these animals the occurrence of the glomerular of the American Rheumatism Association (ARA) lesions is particularly associated with antigen- and certain immunological criteria (antinuclear dependent histamine release from leucocytes2; and, antibodies, anti-DNA antibodies and low serum on addition of the antigen, basophils sensitised complement). All patients had renal involvement, with IgE degranulate and release also a platelet- shown by renal biopsy, confirmed by light micro- activating factor (PAF) which aggregates platelets scopy, immunofluorescence, and in some cases and releases their histamine.3 We have recently electron microscopy. shown that a diminution of circulating basophils on September 26, 2021 by guest. Protected precedes the onset of proteinuria in acute experi- STAINING AND COUNTING OF BASOPHILS mental serum sickness; and those rabbits whose The technique has been described previously in basophil count remained normal showed no pro- rabbits,9 but it has also been found useful for human teinuria, although they had circulating immune basophil counting.'0 Briefly, blood and dye were complexes bigger than 19 S in size.4 mixed in a 1/10 proportion and placed in both The role of immediate hypersensitivity in immune chambers of a Fuchs-Rosenthal cell. Cells were complex diseases in man has received little atten- counted at a magnification of 200. With this tech- tion.5-8 Accordingly, the purpose ofthis work was to nique basophils were the only cells with stained study the implication of the IgE-basophil system in cytoplasm. The counts were performed by 2 persons, systemic lupus erythematosus, a prototype of neither of them knowing the clinical situation or the immune complex disease in man. treatment received by the patients. Samples were drawn in the morning. Average absolute basophil counts and percentage of basophils in relation to the Accepted for publication 22 August 1979. total leucocyte count in 47 control subjects were Correspondence to Dr J. Egido, Laboratorio de Nefrologia, ± ± 0 34 Fundaci6n Jim6nez Dfaz, Avda. Reyes Cat6licos 2, Madrid- respectively 44 5 15 (SD)/mm3 and 0*51 3, Spain. (SD). 312 Ann Rheum Dis: first published as 10.1136/ard.39.4.312 on 1 August 1980. Downloaded from Evidence ofan immediate hypersensitivity mechanism in systemic lupus erythematosus 313 BASOPHIL DEGRANULATION UTILISING POLYETHYLENE GLYCOL (PEG) PRECIPITATION SONICATED DNA FOR DETECTION OF PRESUMPTIVE This was undertaken in 6 patients during periods IMMUNE COMPLEXES when their basophil count were within normal limits. Diluted sera were mixed in equal portions with Since native DNA preparations are viscous, due to PEG (6000 Merck) solution (borate buffer) at a their high molecular weight, these are technically final PEG concentration of 355%.16 The washed unsuitable for degranulation studies. Accordingly, precipitate was dissolved in sodium hydroxide, and calf thymus DNA (Sigma type 1) at a concentration the quantity of precipitated protein present was of 10 ,ug/ml was sonicated in an ice bath using a measured by optical density (OD) at 280 nm. The Branson W185 sonicator for 40 seconds at maximum threshold ofpositivity was taken as 0 * 130 OD, which output in order to obtain uniform fragments of represents two standard deviations above the mean approximately 106 daltons.11 This DNA was con- value for 60 normal controls. The higher values were sidered immunologically as native DNA (n-DNA) considered positive, the lower values negative. because in inhibition studies (kindly performed by Dr Picazo) it was totally unreactive with rabbit COMPLEMENT antisera to denatured DNA.12 Whole blood of lupus Serum levels of C3, C4, and C3PA were measured by patients (10 ml in tubes with heparin) was distributed radial immunodiffusion, following Mancini's tech- in 5 ml plastic tubes in 1 ml aliquots. 10 Vul of a DNA nique17 (Behring Partigen plates). solution in Tris buffer, 0' 2M, pH 8, at final con- centrations of 0 01, 0.1, 1 and 10 Vg, were added. Results Two tubes were used as controls. One contained 10 Vg of unrelated protein (bovine serum albumin) and the other contained neither antigen nor BSA. CIRCULATING BASOPHIL COUNT AND ITS RELATIONSHIP WITH ANTI-DNA Tubes were placed at 370C under constant motion copyright. for 15 minutes, after which 25 ,ul of 0-2 M EDTA, ANTIBODIES, SERUM C3, C4, AND C3PA pH 7 4, was added to stop the reaction, and the LEVELS, AND PEG PRECIPITATION samples were placed in a rotator. Each sample was Seventy-one determinations were made in the 30 counted twice and the percentage of basophil lupus patients in different stages of disease activity. degranulation was calculated from the following The average absolute basophil count and the formula: percentage of basophils in relation to the total leucocytes in lupus patients was of 16 08 17 Mean no. of basophils in control samples -mean no. ± basophils in test x 100. (SD)/mm3 and 0 30 ± 0 23, significantly low with http://ard.bmj.com/ Mean no. of basophils in control samples respect to controls (P<0.0005 and P<0 005 To show that degranulation is calcium-dependent respectively). The basophil count in 67 nonlupus and therefore meaningful, the degranulation test patients with biopsy evidence of glomerulonephritis was repeated at optimum DNA concentration in (minimal changes, mesangiocapillary, membranous, the presence of 5 mM EDTA. and IgA mesangial glomerulonephritis) has not shown significant differences from the controls (data MEASURE OF IgE ON THE BASOPHIL SURFACE not shown). on September 26, 2021 by guest. Protected IgE on the basophil surface was determined on 7 In order to study whether a depressed circulating lupus patients at different times by a radioimmuno- basophil count represented another sign of lupus assay method previously described.13 The assay activity this parameter was compared with some system was based on the capacity of unlabelled immunological data generally considered to be immunoglobulin to inhibit the reaction between 'markers' of activity. Correlations emerged between labelled IgE protein and anti-IgE.14 circulating basophil count and DNA antibodies (expressed as DNA-binding percentage) and serum ANTI-DNA ANTIBODY DETERMINATION C3 and C4 levels; these relationships are shown in The method used was that of precipitation with 50% Figs. 1, 2, and 3, respectively. No correlation was saturated ammonium sulphate, using Escherichia found with serum C3PA levels. The relationship Coli DNA labelled with 14C, following Farr's between basophil counts and PEG precipitation technique.15 Binding values under 30% were con- in 28 patients is shown in Fig. 4. In those patients sidered normal. Sera were heated at 560C for 30 having a positive precipitation with PEG the average minutes to eliminate nonspecific binding of DNA basophil count was 9-42 ± 6-95 (SD)/mm3, while to Clq. All readings were made in duplicate, and a it was 19 40 ± 14.87/mm3 in those having it control serum with a known binding value was negative (P<0-001). A significant correlation was included in each test. also found when we compared the average values Ann Rheum Dis: first published as 10.1136/ard.39.4.312 on 1 August 1980. Downloaded from 314 Egido, Sdnchez Crespo, Lahoz, Garcia, Lopez-Trascasa, Hernando E SD of the percentage of basophils in relation greater than 30% (Fig. 5). Maximal degranulation to the total leucocytes (0-20 ± 0-14 versus 0 44 + was reached at 1 Vg DNA/ml, except in the patient.' 0 31) in these 2 groups. In the majority of the patients the dose-response curves were similar to those obtained by the same CIRCULATING BASOPHIL SENSITISATION technique in patients sensitised against different WITH RESPECT TO NATIVE DNA drugs.10 In all patients basophil degranulation was Five out of 6 patients whose basophils were incu- inhibited when the test was performed in the pre- bated with sonicated DNA showed degranulation sence of 5 mM EDTA. % 6DNA bindinq r =-0,552 p <o,oo1 Fig. 1 Correlation between the number ofcirculating basophils stained by a modified toluidine blue and the DNA antibodies, expressed as DNA-binding percentage. copyright. 5 10 15 45 So Basoph/s/lMm3 http://ard.bmj.com/ C'3 mg%. .470 * 200 on September 26, 2021 by guest. Protected Fig. 2 Correlation between the number of circulating basophils r= 0,557 and serum C3 p< 0,00f ,40.
Recommended publications
  • Anti-Thymocyte Globulin (Atg) and Ciclosporin (Csa)
    Myeloid group ANTI-THYMOCYTE GLOBULIN (ATG) AND CICLOSPORIN (CSA) INDICATION ATG and CSA is indicated for patients who require treatment for aplastic anaemia (AA) but who are not eligible for sibling donor BMT. This includes (note references to severity are based on the modified Camitta criteria): Patients with non-severe aplastic anaemia who are dependent on red cell and/or platelet transfusions. Patients with severe aplastic anaemia (SAA) or very SAA who are > 35-50 years of age. Patients with SAA or very SAA disease who lack an HLA-compatible sibling donor. Protocol may be used in selected patients with hypoplastic marrow conditions. Patients with severe AA who are ≤ 35 years old and have a HLA identical sibling donor, should be treated with allogenic bone marrow transplantation as soon as possible after diagnosis. TREATMENT INTENT Prolong survival Provide a rapid (within 3 months) and sustained improvement in peripheral blood counts Restore haematopoiesis PRE-ASSESSMENT 1. ATG should only used by physicians familiar with administering ATG. Medical and nursing teams must be aware of the side effects and how to treat promptly and appropriately. 2. ATG is highly immunosuppressive - only use in centres with at least level 2 facilities. Patients should be nursed in a single or double isolation room, as an inpatient. 3. Risk of transfusion-associated GvHD following treatment with ATG is unclear, therefore irradiated blood components are currently recommended. It is not known how long the use of irradiated products This is a controlled document and therefore must not be changed Page 1 of 9 ML.2 ATG & CSA Authorised by Myeloid Lead Oct 2019 V.4.1 Prof Adam Mead Myeloid group should be continued, but it may be reasonable to continue while patients are still taking CSA following ATG therapy.
    [Show full text]
  • I Have Spots and My Skin Burns
    I have spots and my skin burns Patient presentation History Differential diagnosis Examination Investigations Discussion Treatment Final Outcome References Evaluation - Questions & answers MCQs Patient presentation Peter, a 60 year-old Caucasian policeman, complains of a painful burning sensation in his lower extremities lasting for several months. Lower limbs petechiae (small purple/red hemorrhagic spots) appeared one week ago. Acknowledgement This case study was provided by Prof. Olivier Boyer (M.D., Ph.D., Head of the Department of Immunology and Biotherapy, Rouen University Hospital, France) and Dr. Maëlle Le Besnerais (M.D., Assistant Professor of Internal Medicine, Rouen University Hospital, France) of the Faculty of Medicine of Rouen, Normandy University, France. The authors would like to thank David Saadoun, Odile Goria, Lucie Guyant-Maréchal and Fabienne Jouen for their critical reading of this case study, Isabelle Duval for the development of pictures and Laetitia Demoulins for technical assistance. We are grateful to Nikki Sabourin-Gibbs, Rouen University Hospital, for her help in editing the manuscript. Immunopaedia.org.za History Peter complains of chronic fatigue and aching joints which started several months ago. He denies significant alcohol consumption and intravenous drug abuse. He received a blood transfusion after a gunshot injury to his arm 35 years ago. He reports distal paraesthesia (tingling or numbness) of both legs and painful burning in both feet which has progressed to the lower and upper limbs. Knee pain wakes him up at night. Past medical history None No allergies Surgical history Appendix removed at 10 years old Arm gunshot injury 35 years ago Family history His father has hypertension and type 2 diabetes Travel history He traveled to Thailand 25 years ago Social history Policeman, married, two children Medication None Differential diagnosis IgA vasculitis Polyarteritis nodosa ANCA-associated vasculitis (eg.
    [Show full text]
  • Penicillin Allergy Guidance Document
    Penicillin Allergy Guidance Document Key Points Background Careful evaluation of antibiotic allergy and prior tolerance history is essential to providing optimal treatment The true incidence of penicillin hypersensitivity amongst patients in the United States is less than 1% Alterations in antibiotic prescribing due to reported penicillin allergy has been shown to result in higher costs, increased risk of antibiotic resistance, and worse patient outcomes Cross-reactivity between truly penicillin allergic patients and later generation cephalosporins and/or carbapenems is rare Evaluation of Penicillin Allergy Obtain a detailed history of allergic reaction Classify the type and severity of the reaction paying particular attention to any IgE-mediated reactions (e.g., anaphylaxis, hives, angioedema, etc.) (Table 1) Evaluate prior tolerance of beta-lactam antibiotics utilizing patient interview or the electronic medical record Recommendations for Challenging Penicillin Allergic Patients See Figure 1 Follow-Up Document tolerance or intolerance in the patient’s allergy history Consider referring to allergy clinic for skin testing Created July 2017 by Macey Wolfe, PharmD; John Schoen, PharmD, BCPS; Scott Bergman, PharmD, BCPS; Sara May, MD; and Trevor Van Schooneveld, MD, FACP Disclaimer: This resource is intended for non-commercial educational and quality improvement purposes. Outside entities may utilize for these purposes, but must acknowledge the source. The guidance is intended to assist practitioners in managing a clinical situation but is not mandatory. The interprofessional group of authors have made considerable efforts to ensure the information upon which they are based is accurate and up to date. Any treatments have some inherent risk. Recommendations are meant to improve quality of patient care yet should not replace clinical judgment.
    [Show full text]
  • Letters to the Editor
    LETTERS TO THE EDITOR Complications of plasma exchange in after percutaneous insertion of a subclavian central ve- thrombotic thrombocytopenic nous catheter from pneumothorax and hemorrhage. Two purpura-hemolytic uremic syndrome: patients suffered cardiac arrest with pulseless electrical a study of 78 additional patients activity: one from an anaphylactic reaction to plasma and The frequency of patients treated with plasma exchange the other from pericardial hemorrhage and tamponade, (PE) for thrombotic thrombocytopenic purpura- presumably due to cardiac perforation by an internal hemolytic uremic syndrome (TTP-HUS) increased seven- jugular catheter insertion guidewire. fold from 1981 to 1997.1 Therefore, the morbidity and Other major catheter-related complications included mortality due to PE is an increasingly important consid- one patient with a retroperitoneal hemorrhage following eration in management decisions for patients with clini- femoral catheter insertion and seven patients with cath- cally suspected TTP-HUS. Some studies have described eter thrombosis that prevented PE and/or required place- few complications associated with PE,2 but our previous ment of a new central venous catheter; two of these seven report on 71 consecutive patients with clinically sus- patients had catheter-related venous thrombosis requir- pected TTP-HUS treated with PE from 1996 to 1999 dem- ing systemic anticoagulation. Ten patients developed sys- onstrated a major complication rate of 30 percent, in- temic infection: eight had blood cultures positive for the cluding two deaths.3 This report describes our experience presence of bacteria (Staphylococcus aureus [five], Staph- during the subsequent 3 years, 1999 to 2002, with 78 con- ylococcus epidermidis [three]); the two patients with secutive patients.
    [Show full text]
  • Hypersensitivity Reactions (Types I, II, III, IV)
    Hypersensitivity Reactions (Types I, II, III, IV) April 15, 2009 Inflammatory response - local, eliminates antigen without extensively damaging the host’s tissue. Hypersensitivity - immune & inflammatory responses that are harmful to the host (von Pirquet, 1906) - Type I Produce effector molecules Capable of ingesting foreign Particles Association with parasite infection Modified from Abbas, Lichtman & Pillai, Table 19-1 Type I hypersensitivity response IgE VH V L Cε1 CL Binds to mast cell Normal serum level = 0.0003 mg/ml Binds Fc region of IgE Link Intracellular signal trans. Initiation of degranulation Larche et al. Nat. Rev. Immunol 6:761-771, 2006 Abbas, Lichtman & Pillai,19-8 Factors in the development of allergic diseases • Geographical distribution • Environmental factors - climate, air pollution, socioeconomic status • Genetic risk factors • “Hygiene hypothesis” – Older siblings, day care – Exposure to certain foods, farm animals – Exposure to antibiotics during infancy • Cytokine milieu Adapted from Bach, JF. N Engl J Med 347:911, 2002. Upham & Holt. Curr Opin Allergy Clin Immunol 5:167, 2005 Also: Papadopoulos and Kalobatsou. Curr Op Allergy Clin Immunol 7:91-95, 2007 IgE-mediated diseases in humans • Systemic (anaphylactic shock) •Asthma – Classification by immunopathological phenotype can be used to determine management strategies • Hay fever (allergic rhinitis) • Allergic conjunctivitis • Skin reactions • Food allergies Diseases in Humans (I) • Systemic anaphylaxis - potentially fatal - due to food ingestion (eggs, shellfish,
    [Show full text]
  • Unique Urticarial Presentation of Minocycline-Induced Lupus
    Volume 23 Number 8 | August 2017 Dermatology Online Journal || Case Report DOJ 23 (8): Unique urticarial presentation of minocycline-induced lupus erythematosus Ashley K Clark1, Vivian Y Shi2 MD, Raja K Sivamani3,4 MD MS CAT Affiliations: 1School of Medicine, University of California, Davis, Sacramento, CA USA, 2Department of Medicine, Division of Dermatology, University of Arizona, Tucson, USA, 3Department of Dermatology, University of California, Davis, Sacramento, CA USA, 4Department of Biological Sciences, California State Univeristy, Sacramento, CA USA Corresponding Author: Raja Sivamani, MD MS CAT, Department of Dermatology, University of California, Davis, 3301 C Street, Suite 1400, Sacramento, CA 95816, Tel: 916-703-5145, Fax: 916-734-7183, Email: [email protected] Abstract with minocycline-induced lupus (MIL) typically present with fever and polyarthralgia, ANA positivity, We present a 17-year-old boy who developed a and elevated erythrocyte sedimentation rate, but generalized urticarial eruption, malar rash, fever, and negative levels of antihistone antibodies (AHAs) arthralgia within one week of initiating minocycline and anti-native DNA antibodies [4, 5]. Our report therapy for acne. His workup showed positive anti- highlights an unusual urticarial presentation of MIL nuclear and anti-histone antibodies. His symptoms with rapid resolution after oral prednisone. To the best quickly resolved after discontinuing minocycline and of our knowledge there is only one case of DIL with starting oral prednisone. We believe the constellation an urticarial presentation. The purpose of this report of his symptoms, laboratory findings, and temporal is to increase recognition of a unique presentation of association of minocycline initiation was suggestive DIL following minocycline treatment.
    [Show full text]
  • Topic: Type II and Type III Hypersensitivity Reactions
    Topic: Type II and Type III Hypersensitivity reactions SOS In Microbiology M.Sc 2nd Semester Paper code: 202 (Immunology) Unit 4 Antibody-Mediated Cytotoxic (Type II) Hypersensitivity • Type II hypersensitive reactions involve antibody-mediated • destruction of cells. Antibody can activate the complement • system, creating pores in the membrane of a foreign cell (see • Figure 13-5), or it can mediate cell destruction by antibodydependent cell-mediated cytotoxicity (ADCC). • In this process, • cytotoxic cells with Fc receptors bind to the Fc region of • antibodies on target cells and promote killing of the cells (see • Figure 14-12).Antibody bound to a foreign cell also can serve • as an opsonin, enabling phagocytic cells with Fc or C3b receptors • to bind and phagocytose the antibody-coated cell 1. Transfusion Reactions • A large number of proteins and glycoprotein on the membrane of red blood cells are called blood group antigen. In addition antibodies are also found in blood for these epitopes except from which are showing on our blood cells (Blood group A, antibody against B epitop). • An individual possessing one form of blood group antigen can recognize other antigen (present in transfused blood) as foreign and elicit immune response. • In some cases, the antibodies have already been induced by natural exposure to similar antigenic determinants on a variety of microorganisms present in the normal flora of the gut. This is the case with the ABO blood-group antigens. • Antibodies to the A, B, and O antigens, called isohemagglutinins ( usulayy of IgM class). A • An individual with blood type A, for example, recognizes B-like epitopes on intestinal microorganisms and produces isohemagglutinins to the B-like epitopes.
    [Show full text]
  • Human Idiopathic Membranous Nephropathy — a Mystery Solved? Richard J
    The new england journal of medicine editorials Human Idiopathic Membranous Nephropathy — A Mystery Solved? Richard J. Glassock, M.D. Just over 50 years ago, the late David Jones1 iden­ were fulfilled, defining the autoimmune nature tified (using the periodic acid–Schiff and meth­ of the disease in the rat model. enamine silver stains) the unique glomerular However, translation of the pathogenesis of pathologic features of membranous nephropathy, the rat model to idiopathic membranous nephrop­ thus distinguishing it from other causes of “ne­ athy in humans proved difficult. The target an­ phrotic glomerulonephritis.” Subsequent immuno­ tigen responsible for Heymann’s model appeared fluorescence and electron­microscopical studies to be absent in human kidneys.6 Diligent search­ established that membranous nephropathy was es for the autoantibody against the “Heymann” also characterized by striking granular aggrega­ antigen (now known to be megalin [glycoprotein tions of IgG and electron­dense deposits along 330]) were unrewarding.6 Thus, the true patho­ the outer (or subepithelial) aspect of the glomer­ genesis of human idiopathic membranous ne­ ular basement membrane. These glomerular IgG phropathy remained unresolved. deposits were initially believed to represent an Now, this long­lasting mystery may well have accumulation of immune complexes arising from been solved by Beck et al.,7 as reported in this the circulation, as is found with glomerulonephri­ issue of the Journal. Autoantibodies against an tis in a rabbit model (chronic serum sickness). antigen normally expressed on the podocyte cell In 1959, Heymann et al.2 described a rat mod­ membrane in humans, the M­type phospholipase el of membranous nephropathy, similar to the dis­ A2 receptor (PLA2R), appear to circulate and bind ease in humans, induced by active immunization to a conformational epitope (or epitopes) present with crude kidney extracts in complete Freund’s on PLA2R, producing in situ deposits character­ adjuvant.
    [Show full text]
  • Another Brick in the Wall: Serum Sickness
    Scholars Journal of Medical Case Reports ISSN 2347-6559 (Online) Sch J Med Case Rep 2017; 5(10):615-617 ISSN 2347-9507 (Print) ©Scholars Academic and Scientific Publishers (SAS Publishers) (An International Publisher for Academic and Scientific Resources) Does So Frequent Use Of It Make Innocent? Another Brick In The Wall: Serum Sickness Induced By Horse-Antithymocyte Globulin In A Patient With Bone Marrow Failure Gokhan Ozgur1, Adem Aydin2, Musa Baris Aykan3, Murat Yildirim4, Selim Sayin5, Cengiz Beyan6 1Gülhane Training and Research Hospital, Clinical of Hematology, Etlik, Ankara, Turkey 2Health Sciences University, Gulhane School of Medicine, Department of Internal Medicine, Etlik, Ankara, Turkey 3TOBB University of Economics and Technology Faculty of Medicine, Department of Internal Medicine, Çankaya, Ankara, Turkey Abstract: Aplastic anemia is a condition characterized by the absence or decrease *Corresponding author of hematopoietic progenitor cells in the bone marrow. The disease is considered to Adem Aydin occur as a result of immune response triggered by the environmental factors, infective agents or endogenous antigens. Cyclosporine and antithymocyte globulin Article History is recommended as first line therapy in patients have no unidentified suitable donor Received: 22.09.2017 or hematopoietic stem cell transplantation cannot be done. However, despite skin Accepted: 09.10.2017 testing for hypersensitivity and concomitant steroids, adverse effects are sometimes Published:30.10.2017 unavoidable. 30-year-old female patient, fallowed with aplastic anemia since 2012, was admitted to hospital with painful swelling in the neck, rash and joint pain DOI: began after ATG. Laboratory examination revealed pancytopenia, elevated 10.21276/sjmcr.2017.5.10.5 erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).
    [Show full text]
  • Equine Anti-Thymocyte Globulin (ATGAM) Administration in Patient
    Open Access Journal of Clinical Nephrology Case Report Equine Anti-Thymocyte Globulin (ATGAM) administration in patient ISSN 2576-9529 with previous rabbit Anti-Thymocyte Globulin (Thymoglobulin) induced serum sickness: A case report 1 2 3 *Address for Correspondence: Joseph B Pryor, Joseph B Pryor *, Ali J Olyaei , Joseph B Lockridge and Douglas J MD Candidate, Oregon Health and Science 4 Norman University, School of Medicine, Portland, Email: 1 [email protected] MD Candidate, Oregon Health and Science University, School of Medicine, Portland 2Professor of Medicine & Pharmacotherapy, Pharmacy Practice/ Nephrology & Hypertension, Submitted: 08 March 2018 Oregon State University/Oregon Health & Science University, Portland Approved: 22 March 2018 3 Published: 23 March 2018 Assistant Professor of Medicine & Medical Director, Division of Nephrology, Department of Medicine, Oregon Health and Science University and Portland VA Medical Center, Portland Copyright: 2018 Pryor JB. et al. This is 4Professor of Medicine & Director, Immunogenetics Laboratory, Division of Nephrology, Department an open access article distributed under the Creative Commons Attribution License, which of Medicine, Oregon Health and Science University and Portland VA Medical Center, Portland permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Keywords: Thymoglobulin; ATGAM; Serum sickness; Kidney transplantation Thymoglobulin is a rabbit-derived anti-thymocyte antibody directed at T-cells and commonly used for induction immunosuppression therapy in solid organ transplantation, especially in immunologically high risk kidney transplant recipients. Despite its frequent use and effi cacy, the heterologous makeup of thymoglobulin can induce the immune system resulting in serum sickness which typically presents with rash, fever, fatigue, and poly-arthralgia in the weeks following drug exposure.
    [Show full text]
  • Serum Sickness Following Treatment with Rituximab
    Case Report Serum Sickness Following Treatment with Rituximab DERRICK J. TODD and SIMON M. HELFGOTT ABSTRACT. Serum sickness, an illness characterized by fever, rash, and arthralgias, can occur in patients who receive chimeric monoclonal antibody therapy. Rituximab, a B cell-depleting chimeric anti-CD20 mon- oclonal antibody, has been used with increasing frequency in the treatment of rheumatologic illnesses such as rheumatoid arthritis and systemic lupus erythematosus. Serum sickness has only rarely been reported following rituximab therapy. All prior reported cases have been in patients with autoimmune conditions. We describe a case of serum sickness in a patient treated with rituximab for mantle cell lym- phoma. We also review the literature of rituximab-induced serum sickness. (First Release Jan 15 2007; J Rheumatol 2007;34:430–3) Key Indexing Terms: SERUM SICKNESS RITUXIMAB ARTHRITIS CASE REPORT ADVERSE DRUG REACTION From the Department of Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, Boston, Massachusetts, USA. tissue damage on being deposited in target tissues, recruiting sickness from rituximab has only rarely been reported. We complement and activating mast cells and phagocytes. Serum describe a case of serum sickness that manifested as fever, sickness usually presents 10–14 days following primary anti- rash, and polyarthritis occurring 13 days after a single dose of gen exposure or within a few days of secondary antigen expo- rituximab for B cell lymphoma. We also review the literature sure. Symptoms include fever, rash, and arthralgias. On occa- regarding rituximab-induced serum sickness. To our knowl- sion an overt arthritis can develop. Inflammatory markers are edge, this is the first documented case of serum sickness in a typically elevated, and serum complement concentrations may patient who received rituximab for a hematologic malignancy.
    [Show full text]
  • Diseases of the Immune System 813
    Chapter 19 | Diseases of the Immune System 813 Chapter 19 Diseases of the Immune System Figure 19.1 Bee stings and other allergens can cause life-threatening, systemic allergic reactions. Sensitive individuals may need to carry an epinephrine auto-injector (e.g., EpiPen) in case of a sting. A bee-sting allergy is an example of an immune response that is harmful to the host rather than protective; epinephrine counteracts the severe drop in blood pressure that can result from the immune response. (credit right: modification of work by Carol Bleistine) Chapter Outline 19.1 Hypersensitivities 19.2 Autoimmune Disorders 19.3 Organ Transplantation and Rejection 19.4 Immunodeficiency 19.5 Cancer Immunobiology and Immunotherapy Introduction An allergic reaction is an immune response to a type of antigen called an allergen. Allergens can be found in many different items, from peanuts and insect stings to latex and some drugs. Unlike other kinds of antigens, allergens are not necessarily associated with pathogenic microbes, and many allergens provoke no immune response at all in most people. Allergic responses vary in severity. Some are mild and localized, like hay fever or hives, but others can result in systemic, life-threatening reactions. Anaphylaxis, for example, is a rapidly developing allergic reaction that can cause a dangerous drop in blood pressure and severe swelling of the throat that may close off the airway. Allergies are just one example of how the immune system—the system normally responsible for preventing disease—can actually cause or mediate disease symptoms. In this chapter, we will further explore allergies and other disorders of the immune system, including hypersensitivity reactions, autoimmune diseases, transplant rejection, and diseases associated with immunodeficiency.
    [Show full text]